122 related articles for article (PubMed ID: 22060087)
1. Stroke risk and NSAIDs: an Australian population-based study.
Caughey GE; Roughead EE; Pratt N; Killer G; Gilbert AL
Med J Aust; 2011 Nov; 195(9):525-9. PubMed ID: 22060087
[TBL] [Abstract][Full Text] [Related]
2. Use of non-steroidal anti-inflammatory drugs and risk of ischemic and hemorrhagic stroke in the Australian veteran community.
Mangoni AA; Woodman RJ; Gilbert AL; Knights KM
Pharmacoepidemiol Drug Saf; 2010 May; 19(5):490-8. PubMed ID: 20437458
[TBL] [Abstract][Full Text] [Related]
3. Association of short-term use of nonsteroidal anti-inflammatory drugs with stroke in patients with hypertension.
Chuang SY; Yu Y; Sheu WH; Tsai YT; Liu X; Hsiung CA; Tsai HJ
Stroke; 2015 Apr; 46(4):996-1003. PubMed ID: 25737315
[TBL] [Abstract][Full Text] [Related]
4. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
[TBL] [Abstract][Full Text] [Related]
5. Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke.
Roumie CL; Mitchel EF; Kaltenbach L; Arbogast PG; Gideon P; Griffin MR
Stroke; 2008 Jul; 39(7):2037-45. PubMed ID: 18436878
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
Haag MD; Bos MJ; Hofman A; Koudstaal PJ; Breteler MM; Stricker BH
Arch Intern Med; 2008 Jun; 168(11):1219-24. PubMed ID: 18541831
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
8. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.
Moore RA; Derry S; McQuay HJ
BMC Musculoskelet Disord; 2007 Aug; 8():73. PubMed ID: 17683540
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
Gunter BR; Butler KA; Wallace RL; Smith SM; Harirforoosh S
J Clin Pharm Ther; 2017 Feb; 42(1):27-38. PubMed ID: 28019014
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study.
Andersohn F; Schade R; Suissa S; Garbe E
Stroke; 2006 Jul; 37(7):1725-30. PubMed ID: 16728684
[TBL] [Abstract][Full Text] [Related]
11. NSAID use in individuals at risk of renal adverse events: an observational study to investigate trends in Australian veterans.
Roughead EE; Ramsay E; Pratt N; Gilbert AL
Drug Saf; 2008; 31(11):997-1003. PubMed ID: 18840019
[TBL] [Abstract][Full Text] [Related]
12. Stroke risk and NSAIDs: a systematic review of observational studies.
Varas-Lorenzo C; Riera-Guardia N; Calingaert B; Castellsague J; Pariente A; Scotti L; Sturkenboom M; Perez-Gutthann S
Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1225-36. PubMed ID: 21971833
[TBL] [Abstract][Full Text] [Related]
13. Cause for concern in the use of non-steroidal anti-inflammatory medications in the community--a population-based study.
Adams RJ; Appleton SL; Gill TK; Taylor AW; Wilson DH; Hill CL
BMC Fam Pract; 2011 Jul; 12():70. PubMed ID: 21733195
[TBL] [Abstract][Full Text] [Related]
14. Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community.
Mangoni AA; Woodman RJ; Gaganis P; Gilbert AL; Knights KM
Br J Clin Pharmacol; 2010 Jun; 69(6):689-700. PubMed ID: 20565461
[TBL] [Abstract][Full Text] [Related]
15. Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study.
Bak S; Andersen M; Tsiropoulos I; García Rodríguez LA; Hallas J; Christensen K; Gaist D
Stroke; 2003 Feb; 34(2):379-86. PubMed ID: 12574546
[TBL] [Abstract][Full Text] [Related]
16. All-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: a longitudinal study.
Kerr SJ; Rowett DS; Sayer GP; Whicker SD; Saltman DC; Mant A
Br J Clin Pharmacol; 2011 Jun; 71(6):936-42. PubMed ID: 21276041
[TBL] [Abstract][Full Text] [Related]
17. Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project.
Schink T; Kollhorst B; Varas Lorenzo C; Arfè A; Herings R; Lucchi S; Romio S; Schade R; Schuemie MJ; Straatman H; Valkhoff V; Villa M; Sturkenboom M; Garbe E
PLoS One; 2018; 13(9):e0203362. PubMed ID: 30231067
[TBL] [Abstract][Full Text] [Related]
18. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
Motsko SP; Rascati KL; Busti AJ; Wilson JP; Barner JC; Lawson KA; Worchel J
Drug Saf; 2006; 29(7):621-32. PubMed ID: 16808554
[TBL] [Abstract][Full Text] [Related]
19. COX-2 inhibitor and non-selective NSAID use in those at increased risk of NSAID-related adverse events: a retrospective database study.
Gadzhanova S; Ilomäki J; Roughead EE
Drugs Aging; 2013 Jan; 30(1):23-30. PubMed ID: 23179898
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident.
Abraham NS; El-Serag HB; Hartman C; Richardson P; Deswal A
Aliment Pharmacol Ther; 2007 Apr; 25(8):913-24. PubMed ID: 17402995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
